Browse the latest research summaries in the field of genetics for spinal cord injury patients and caregivers.
Showing 231-240 of 1,773 results
Neurochemical Research, 2023 • August 16, 2022
This review discusses the role of LncRNAs in spinal cord injury, highlighting their involvement in inflammatory damage, apoptosis, and nerve healing. It summarizes the regulatory role and molecular me...
KEY FINDING: Bioinformatics analysis of differentially expressed RNAs after spinal cord injury provides a foundation for in vitro and in vivo experiments on gene molecular targets. Further development is needed to verify their function and explore their mechanisms in organisms.
Cellular and Molecular Neurobiology, 2022 • April 22, 2021
This review provides an overview of miR-124, its roles in CNS development, and summarizes recent data of its role in neuroinflammation, ischemic stroke, SCI, NDDs, GBM, MS, and the methods for the del...
KEY FINDING: miR-124 acts as one of the key miRNAs regulating neuroinflammation in various CNS pathologies, which may shed light on novel therapies targeting miR-124 for treating CNS insults.
The Journal of Spinal Cord Medicine, 2023 • January 1, 2023
This study aimed to investigate the effect of Buyang Huanwu decoction (BYHWD) on neural recovery after spinal cord injury (SCI) in rats, focusing on the mTOR signaling pathway and autophagy. The resul...
KEY FINDING: BYHWD improved motor function in SCI rats. Specifically, low, medium, and high doses of BYHWD showed improvements, with the high dose showing the most significant effect.
Int. J. Mol. Sci., 2023 • October 31, 2023
This study aimed to induce neuronal features in adult canine dermal fibroblasts (ACDFs) using small molecules (SMs) and to assess the permanency of these changes, addressing the need for efficient neu...
KEY FINDING: Adult canine dermal fibroblasts (ACDFs) treated with eight small molecules (SMs) developed neuron-like morphology, including a round-shaped cell body with branching processes.
Cancer Immunology, Immunotherapy, 2022 • January 27, 2022
This study used single-cell RNA sequencing to map the transcriptomic landscape of chordomas, revealing significant intratumoral heterogeneity and potential therapeutic targets. The analysis identified...
KEY FINDING: Chordoma tumors exhibit significant intratumoral heterogeneity, with distinct subpopulations of chordoma cells, fibroblasts, and immune cells.
NEURAL REGENERATION RESEARCH, 2022 • February 8, 2022
This study investigates the therapeutic potential of miR-101a-3p mimic in treating spinal cord ischemia/reperfusion injury (SCII) in rats. The research demonstrates that miR-101a-3p expression is redu...
KEY FINDING: miR-101a-3p expression is significantly decreased in the spinal cord after ischemia/reperfusion injury, while MYCN expression is increased.
Neural Regen Res, 2022 • February 28, 2022
The study aimed to analyze the expression and function of lncRNAs after spinal cord injury, which has not been extensively analyzed previously. The study identified dysregulated lncRNAs after SCI and ...
KEY FINDING: Identified 445 differentially expressed lncRNAs and 6522 differentially expressed mRNAs in rats after spinal cord hemisection injury.
Neural Regeneration Research, 2022 • February 28, 2022
This study aimed to analyze the differentially expressed genes between rostral and caudal sites after injury to determine the biological processes in these two segments after SCI. The results indicate...
KEY FINDING: Differentially expressed genes (DEGs) were identified between the rostral and caudal regions at different time points following SCI, including Col3a1, Col1a1, Dcn, Fn1, Kcnk3, and Nrg1.
Brain Pathology, 2022 • January 1, 2022
This study investigates the role and mechanism of lncRNA MEG3 in the M1 polarization of microglia and neuroinflammation in acute spinal cord injury (ASCI). The findings demonstrate that lncRNA MEG3 ex...
KEY FINDING: LncRNA MEG3 expression is decreased in ASCI mouse spinal cord tissues and LPS-treated primary microglia and BV2 cells.
Bioactive Materials, 2022 • February 28, 2022
This study aimed to investigate the molecular mechanisms underlying the observed cell-specific effects of bioactive glasses (BGs) on giant cell tumor of bone-derived stromal cells (GCTSC) and bone mar...
KEY FINDING: BG treatment leads to a significant decrease of cell viability in tumor cells but not in bone marrow cells.